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temperature
Adam H Metherel, Ryan C Hogg, Lindy M Buzikievich and Ken D Stark*Abstract
Background: Dried blood spots (DBS) from fingertip prick blood can enable high throughput fatty acid profiling
but may be prone to lipid peroxidation during storage. The use of butylated hydroxytoluene (BHT) on
chromatography paper can prevent polyunsaturated fatty acid (PUFA) loss but examinations on the length of
storage times possible are not comprehensive.
Method: In the first study, venous whole blood was saturated on paper strips pre-soaked with 0, 2.5 or 5.0 mg/mL
BHT and exposed to air for up to 28 days. In a second study, the effect of sealing DBS on 5.0 mg/mL BHT-soaked
chromatography strips in capped test tubes or vacuum sealed polypropylene bags with and without nitrogen
purging was examined over eight weeks. The fatty acid composition of the DBS were determined by gas
chromatography and the effect of sample storage on omega-3 biomarkers were examined.
Results: PUFA and omega-3 biomarkers in DBS stored without BHT were dramatically reduced by day 3. In general,
BHT delayed decreases in eicosapentaenoic + docosahexaenoic acid from baseline (3.2 ± 0.2 wt%) to 28 days (2.6 ±
0.03 wt%) of storage. In the % n-3 highly unsaturated fatty acids (HUFA) in total HUFA biomarker, BHT was more
effective at preventing changes, particularly with 5.0 mg/mL BHT where no differences were detected up to
28 days. Sealed storage with BHT tended to increase the stability of the PUFA in DBS and nitrogen purging did not
appear to provide additional benefits. The % n-3 HUFA in total HUFA biomarker also appeared to be more stable in
the sealed storage study.
Conclusions: The storage of DBS in sealed containers with BHT may prevent PUFA degradation for up to 8 weeks.
The % n-3 HUFA in total HUFA biomarker appears to provide a more consistent assessment of omega-3 status
throughout storage as compared with other omega-3 blood biomarkers.
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Dried blood spots (DBS) from fingertip prick blood does
not require a trained phlebotmist and can enable high-
throughput screening of blood omega-3 biomarker sta-
tus when combined with direct transesterification and
fast gas chromatography. Omega-3 blood biomarkers are
associated with chronic disease [1-3] and may be useful
for health promotion, disease detection and disease* Correspondence: kstark@uwaterloo.ca
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reproduction in any medium, provided the orprevention strategies in human populations. Previously,
DBS analysis has been validated for the determination of
fatty acid composition in whole blood [4-7], and has
been used to assess fatty acid profiles from elderly
individuals [8], young Canadian adults [9], Italian and
Tibetan adults [10], and mothers and their newborns
[11,12]. Omega-3 blood biomarkers such as the sum of
the percentage of eicosapentaenoic acid (EPA, 20:5n-3)
and docosahexaenoic acid (DHA, 22:6 n-3) (% EPA +
DHA)[1] in erythrocytes and the percentage of omega-3
highly unsaturated fatty acids (HUFA, ≥20 carbons, ≥3al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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HUFA in total HUFA)[3] utilize qualitative fatty acid
values in their calculations, and as such DBS analysis
remains suitable as blood volumes are often unknown.
However, peroxidation of polyunsaturated fatty acids
(PUFA) in blood stored on chromatography paper can
limit the utility of high-throughput DBS sampling.
Previously, decreases in the PUFA content of
erythrocytes are prevented for up to 4 weeks when
stored at −20°C [13,14], and for up to 2 years at −80°C
[15] in the absence of an antioxidant. However, access to
−80°C storage is often limited outside of research
institutions. In 1979, it was demonstrated that butylated
hydroxytoluene (BHT) improves PUFA recovery in the
fatty acid analysis of lipids [16], and it is typically
included in routine fatty acid analyses [17]. The addition
of BHT to erythrocytes for storage extends PUFA stabil-
ity from 4 to 17 weeks [13]. Previously, PUFA in DBS
with BHT treatment were shown to be stable for be-
tween 3 weeks [6] and 3 months [18] at 4°C, and for less
than 2 months [18] at room temperature [18]. The aim
of the present study is to assess the validity of using
different levels of BHT added to chromatography paper
to prevent PUFA degradation in DBS samples stored
openly at room temperature for one month. In addition,
the effect of storing DBS samples with BHT in vacuum
sealed polypropylene bags and in capped test tubes with
and without nitrogen purging for up to 8 weeks at room
temperature on PUFA degradation was examined. This
single individual study will provide a basis for the assess-
ment of these storage methods in more extensive storage
stability protocols that utilize larger sample sizes.Methods
Study design
All procedures and protocols received prior approval
from the Human Research Ethics Committee of the Uni-
versity of Waterloo. In study one, chromatography paper
was soaked in three separate concentrations of 2,6-di-
tert-butyl-4-methylphenol (butylated hydroxytoluene,
BHT, Sigma-Aldrich, St. Louis, MO, USA) in methanol.
Concentrations of BHT in methanol included 0 mg/mL
(control), 2.5 mg/mL and 5 mg/mL [6]. The BHT/
methanol mixture was allowed to travel to the top of
one sheet of chromatography paper (Whatman Ltd.,
Sanford, ME, USA) in a thin layer chromatography tank
before the paper was removed and air dried. The fatty
acid compositions of DBS from each BHT condition
were immediately analyzed in triplicate by gas chroma-
tography at time 0. The remaining samples were stored
in open test tubes and analyzed in triplicate after 1, 3, 7,
14, 21 and 28 days to track changes in fatty acid com-
position due to PUFA degradation.In study two, all strips of chromatography paper were
treated with BHT in methanol at a concentration of
5.0 mg/mL. At time 0, DBS were collected in triplicate
and immediately transesterified for gas chromatography
determination of fatty acid composition. This time 0 de-
termination served as baseline for all four storage
conditions, as the sample collection procedures were
similar across storage conditions. The remaining samples
were randomly assigned to be stored in; a closed screw
cap test tube, a closed screw cap test tube following nitro-
gen purging, a vacuum sealed polypropylene bag sealed
with a commercially available vacuum sealer (Foodsaver
V2840; Sunbeam, Mississauga, ON), or a vacuum sealed
polypropylene bag after nitrogen purging. The fatty acid
composition of three samples from each storage condition
were determined weekly for eight weeks.Blood collection
Blood was obtained by venipuncture from a single
fasting male on two occasions corresponding to study
one and study two. Venous blood was collected from the
antecubital vein into 10 mL evacuated tubes (Vacutainer;
Becton Dickinson, Franklin Lakes, NJ) by a trained tech-
nician and ethylene diaminetetraacetic acid (EDTA) was
added to prevent coagulation. Blood was absorbed onto
the thin strips (1 cm × 3 cm) of chromatography paper
such that an area of approximately 1 cm2 was saturated
using a pasteur pipette.Fatty acid analysis
Fatty acid composition of each DBS was determined
using a method previously described [4]. Fatty acid me-
thyl esters were prepared from DBS by direct
transesterification in 14% boron trifluoride in methanol
(Pierce Chemicals, Rockford, IL, USA) with hexane
using a convectional block heater set at 95°C for 60
minutes. The organic layer containing the fatty acid me-
thyl esters was collected for analysis on a Varian 3900
gas chromatograph (Varian Inc., Mississauga, ON) as
previously described [19]. The gas chromatograph was
equipped with a DB-FFAP 15 m × 0.10 mm i.d. ×
0.10 μm film thickness, nitroterephthalic acid modified,
polyethylene glycol, capillary column (J&W Scientific
from Agilent Technologies, Mississauga, ON) with
hydrogen as the carrier gas. Samples (2 μL) were
introduced by a Varian CP-8400 autosampler into the in-
jector heated to 250°C with a split ratio of 200:1. The
initial temperature was 150°C with a 0.25 min hold
followed by a 35°C/min ramp to 200°C, an 8°C/min ramp
to 225°C with a 3.2 min hold and then an 80°C/min ramp
up to 245°C with a 15 min hold at the end. The flame
ionization detector temperature was 300°C with air and
nitrogen make-up gas flow rates of 300 mL/min and
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Fatty acid compositions of all samples are expressed as
percent weight of individual fatty acids in total fatty
acids. The sum of EPA and DHA (EPA + DHA) and
EPA, DHA and n-3 docosapentaenoic acid (DPAn-3)
(EPA + DHA + DPA n-3), the percentage of n-3 HUFA
in total HUFA, and the ratio of total omega-3 fatty acids
to omega-6 fatty acids (n-3/n-6) were calculated to illus-
trate changes in the omega-3 status in the samples and
the differential rates of degradation in the fatty acid
subclasses.
Statistical analysis
Qualitative values for individual fatty acids and fatty acid
groups are expressed as mean ± SD. All statistical ana-
lyses were performed with the SPSS System (SPSS Inc.,
Chicago, IL). Various fatty acids and fatty acid groups
were examined by one-way ANOVA with individual
means compared following a significant F-value by
Tukey’s Honestly Significant Different (HSD) post hoc
procedure. Significance was inferred at p < 0.05.
Results
The effect of different levels of BHT during open air
storage at room temperature on fatty acid composition
Total PUFA percentages decreased by 49% without BHT,
15% with 2.5 mg/mL BHT and 6% with 5.0 mg/mL BHT
(Table 1). In the HUFA subclass, decreases were 62%
without BHT, 34% with 2.5 mg/mL BHT, and 13% with
5.0 mg/mL BHT. These results indicate increasing BHT
concentrations provided may reduce the degradation of
PUFA and HUFA of DBS. The 5.0 mg/mL BHT condi-
tion also appears to protect levels of arachidonic acid
(ARA), EPA and DHA in DBS. In contrast, saturated fatty
acid (SFA) percentages increased by 30% during storage
without BHT and by 10% with 2.5 mg/mL BHT. Monoun-
saturated fatty acid (MUFA) percentages increased by
24% during storage without BHT and by 9% with
2.5 mg/mL BHT. There was no change in SFA and
MUFA percentages with 5.0 mg/mL BHT by day 28 of
storage.
Without BHT, blood biomarkers of omega-3 fatty acid
status (% n-3 HUFA in total HUFA, EPA + DHA, n-6/n-3
ratio and EPA +DHA +DPAn-3) changed significantly
(p < 0.05) after only 3 days of storage (Figure 1). EPA +
DHA and EPA +DHA+DPAn-3 levels decreased from
baseline (2.84 ± 0.17 and 3.80 ± 0.21, respectively) to day 3
(1.15 ± 0.03 and 1.73 ± 0.14) and remained decreased until
day 28 (0.94 ± 0.05 and 1.31 ± 0.12). Conversely, the
immediate decrease in the % n-3 HUFA in total
HUFA from baseline (27.0 ± 0.6) to day 3 (22.9 ± 1.6)
returned to levels not different (p > 0.05) from base-
line at day 28 (24.4 ± 2.5). The n-6/n-3 ratio increasedfrom baseline (8.2 ± 0.4) up to day 14 of storage (14.2 ± 1.5)
but started to decrease to day 28 (12.5 ± 1.8), although not
significantly (p > 0.05).
Storing DBS in the presence of BHT delayed and in
certain biomarkers prevented the changes in omega-3
status that are observed when DBS are stored without
BHT. With 2.5 mg/mL BHT, baseline % n-3 HUFA in
total HUFA (25.7 ± 0.5) was maintained for up to 21 days
(25.8 ± 0.9). With 5.0 mg/mL BHT, the % n-3 HUFA in
total HUFA did not change from baseline during 28 days.
A similar pattern was observed in the ratio of n-6/n-3,
but the change from baseline (8.17 ± 0.24) to day 28
(11.4 ± 0.3) was more dramatic in the 2.5 mg/mL BHT
condition. There was also a gradual and significant in-
crease in the n-6/n-3 ratio with 5.0 mg/mL BHT. Con-
versely, EPA + DHA and EPA + DHA + DPAn-3
percentages in the DBS samples were decreased signifi-
cantly after only 14 days with 2.5 mg/mL BHTand 21 days
with 5.0 mg/mL BHT.
Fatty acid composition and omega-3 biomarkers during
sealed storage
DBS samples stored with 5.0 mg/mL BHT under sealed
conditions were examined for up to 8 wks (Table 2). In
general, there was a tendency for decreases in the
percentages of n-3 PUFA and increases in the percent-
age of MUFA. These differences were significant in both
the vacuum sealed propylene bag conditions and the ni-
trogen purged sealed test, but surprisingly not in the
sealed test tube without nitrogen purging. Changes in
the % n-3 HUFA in total HUFA of only 0.4 – 2.8% for
all sealed storage conditions throughout the entire study
were not significant (p > 0.05) (Figure 2). The ratio of n-
6/n-3, and the sums of the percentage of EPA + DHA
and EPA + DPAn-3 + DHA demonstrated considerable
variation across the weekly measures with significant
differences in at least one of the storage conditions.
Discussion
Results of the current study indicate that BHT can pro-
vide substantial protection against PUFA degradation in
a DBS sample. Total HUFA composition in DBS remains
stable in the presence of BHT for up to 21 days in open
air although significantly lower levels are observed after
3 and 14 days of storage. Storage stability can be
extended to at least 8 weeks when stored and capped in
a test tube. These results are not in agreement with a
previous study demonstrating that DBS samples
wrapped and sealed in foil were unstable during a 2
month storage period [18]. However, the specific BHT
concentration used in this previous study is not
reported, and as such 5.0 mg/mL of BHT in the present
study may explain the improved stability. In addition,
our samples were stored in test tubes or vacuum packed
Table 1 Weight % of fatty acids in dried blood spots at varying BHT concentrations over 28 days
Name 0 d 1 d 3 d 7 d 14 d 21 d 28 d
0 mg/mL BHT
SFAs 42.1 ± 0.9a 40.2 ± 0.5a 49.2 ± 0.6b 54.1 ± 1.7c 56.0 ± 0.3c 54.3 ± 0.5c 54.9 ± 0.9c
MUFAs 18.0 ± 0.4a 18.7 ± 0.2a 22.3 ± 0.3c 21.3 ± 0.8bc 20.8 ± 0.3b 21.8 ± 0.4bc 22.3 ± 0.7c
N-6 FAs 34.0 ± 0.6a 35.4 ± 0.1b 23.9 ± 0.3c 20.1 ± 0.5d 18.3 ± 0.1e 19.0 ± 0.3de 18.2 ± 0.6e
N-3 FAs 4.17 ± 0.24a 4.14 ± 0.03a 1.98 ± 0.11b 1.45 ± 0.08c 1.30 ± 0.13c 1.63 ± 0.20bc 1.47 ± 0.15c
ARA 8.07 ± 0.14a 8.10 ± 0.17a 4.25 ± 0.07b 3.20 ± 0.14c 2.85 ± 0.07c 3.17 ± 0.10c 2.92 ± 0.22c
EPA 0.65 ± 0.10a 0.64 ± 0.04a 0.29 ± 0.02b 0.26 ± 0.03b 0.25 ± 0.05b 0.25 ± 0.02b 0.17 ± 0.02b
DHA 2.19 ± 0.09a 2.18 ± 0.03a 0.85 ± 0.05b 0.63 ± 0.04cd 0.55 ± 0.02d 0.73 ± 0.02cd 0.77 ± 0.06cd
PUFAs 38.1 ± 0.8a 39.5 ± 0.1b 25.9 ± 0.3c 21.5 ± 0.5d 19.6 ± 0.1e 20.6 ± 0.5de 19.6 ± 0.4e
HUFAs 14.1 ± 0.5a 14.1 ± 0.2a 7.59 ± 0.10b 5.60 ± 0.24cd 5.02 ± 0.22d 5.80 ± 0.08c 5.40 ± 0.19cd
2.5 mg/mL BHT
SFAs 37.1 ± 0.5a 37.1 ± 0.3a 37.6 ± 0.5ab 36.2 ± 0.7a 39.2 ± 0.2c 39.0 ± 0.8bc 40.9 ± 0.7d
MUFAs 19.0 ± 0.2ab 18.7 ± 0.4a 19.1 ± 0.4ab 19.8 ± 0.4c 19.6 ± 0.1bc 20.2 ± 0.2cd 20.7 ± 0.1d
N-6 FAs 36.7 ± 0.3a 36.0 ± 0.3a 35.9 ± 0.1a 36.3 ± 0.4a 34.9 ± 0.5b 34.8 ± 0.4b 32.3 ± 0.3c
N-3 FAs 4.43 ± 0.10a 4.32 ± 0.11ab 4.15 ± 0.17abc 4.35 ± 0.12ab 3.96 ± 0.07bc 3.79 ± 0.25c 2.84 ± 0.06d
ARA 9.12 ± 0.07a 8.43 ± 0.24b 8.28 ± 0.08b 8.40 ± 0.12b 8.08 ± 0.07b 7.56 ± 0.22c 5.98 ± 0.13d
EPA 0.71 ± 0.08a 0.73 ± 0.06a 0.68 ± 0.06a 0.66 ± 0.03ab 0.62 ± 0.02ab 0.63 ± 0.07ab 0.52 ± 0.01b
DHA 2.40 ± 0.19a 2.25 ± 0.10ab 2.17 ± 0.06ab 2.35 ± 0.06a 2.16 ± 0.05ab 1.95 ± 0.20b 1.42 ± 0.05c
PUFAs 41.1 ± 0.2a 40.3 ± 0.3ab 40.0 ± 0.3b 40.6 ± 0.4ab 38.9 ± 0.5c 38.6 ± 0.6c 35.1 ± 0.2d
HUFAs 15.7 ± 0.1a 14.8 ± 0.2bc 14.4 ± 0.2bc 14.9 ± 0.2b 14.2 ± 0.1c 13.4 ± 0.5d 10.4 ± 0.2e
5 mg/mL BHT
SFAs 36.6 ± 0.2 36.9 ± 0.4 37.6 ± 0.8 36.0 ± 0.4 37.9 ± 2.6 38.5 ± 0.9 39.0 ± 0.7
MUFAs 18.6 ± 0.2a 19.0 ± 0.1a 19.2 ± 0.2ab 19.5 ± 0.3ab 21.6 ± 2.4b 20.1 ± 0.6ab 20.4 ± 0.1ab
N-6 FAs 36.0 ± 0.5ab 36.7 ± 0.1a 35.7 ± 0.4abc 36.0 ± 0.5ab 34.2 ± 0.3c 34.8 ± 1.1bc 34.2 ± 0.2c
N-3 FAs 4.59 ± 0.28a 4.23 ± 0.07ab 4.07 ± 0.02bc 4.32 ± 0.08ab 3.73 ± 0.26c 4.16 ± 0.15abc 3.75 ± 0.13c
ARA 8.68 ± 0.15a 8.54 ± 0.19a 8.21 ± 0.11ab 8.53 ± 0.20a 7.60 ± 0.45b 8.35 ± 0.12a 7.72 ± 0.09ab
EPA 0.82 ± 0.08a 0.71 ± 0.03ab 0.62 ± 0.01b 0.66 ± 0.04b 0.60 ± 0.01b 0.62 ± 0.02b 0.61 ± 0.04b
DHA 2.41 ± 0.15a 2.28 ± 0.02a 2.16 ± 0.03ab 2.35 ± 0.03a 1.98 ± 0.19b 2.25 ± 0.11ab 1.96 ± 0.06b
PUFAs 40.6 ± 0.3a 41.0 ± 0.2a 39.7 ± 0.4ab 40.4 ± 0.6ab 37.9 ± 0.6c 39.0 ± 1.0bc 38.0 ± 0.2c
HUFAs 15.5 ± 0.2a 14.8 ± 0.3ab 14.3 ± 0.2bc 15.0 ± 0.3ab 13.2 ± 0.7d 14.8 ± 0.3ab 13.5 ± 0.1cd
Values are means ± SD, n = 3. BHT, butylated hydroxytoluene; SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; FA, fatty acid; n-6, omega-6; n-3,
omega-3; ARA, arachidonic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; PUFA, polyunsaturated fatty acid; HUFA, highly unsaturated fatty acid.
Values with different superscript letters within a row are significantly different by Tukey’s HSD post hoc procedure (P < 0.05) after a significant F-value by one-way
ANOVA (P < 0.05).
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seal than foil wrapping.
BHT mediated protection of PUFA is most likely due
to free radical scavenging by BHT. The phenol group in
BHT is thought to donate a proton to free radicals, thus
neutralizing the free radicals and preventing them from
accepting hydrogen protons from the methylene groups
in PUFA and thereby preventing degradation [20]. The
results of the present study support BHT protection
against PUFA loss as increasing concentrations of BHT
on the chromatography paper demonstrates increased
ability to prevent PUFA degradation. Additionally, stor-
ing DBS in sealable containers further prevents PUFA
loss regardless of storage under an inert gas such as
nitrogen.During open air storage without BHT, omega-3 blood
biomarkers responded differently that appear to be
dependent on how each biomarker is calculated
(Figure 1). Decreases in individual fatty acids from base-
line were 23% for 18:2n-6 (data not shown), 33% for
18:3n-3 (data not shown), 47% for ARA, 55% for EPA
and 61% for DHA (Table 1) that is in agreement with
known kinetic rates of degradation. Omega-3 PUFA have
a greater susceptibility for degradation as compared with
omega-6 PUFA, as omega-3 PUFA generally contain
more double bonds for a given chain length. The kinetic
rates of degradation are 1.4 M-1 s-1 for 18:1n-9, 62
M-1 s-1 for 18:2n-6, 115 M-1 s-1 for 18:3n-3, 197 M-1 s-1


































































































































Figure 1 Omega-3 blood biomarkers in dried blood spot samples
stored with 0, 2.5 or 5 mg/mL BHT over 28 days at room
temperature. BHT, butylated hydroxytoluene; HUFA, highly unsaturated
fatty acid; PUFA, polyunsaturated fatty acid; EPA, eicosapentaenoic acid;
DHA, docosahexaenoic acid; DPAn-3, omega-3 docosapentaenoic acid;
n-3, omega-3; n-6, omega-6. Bars represent means with error bars
representing the S.D., n = 3. Bars with different letters within BHT
condition are significantly different by Tukey’s HSD post hoc procedure
(P < 0.05) after a significant F-value by one-way ANOVA (P < 0.05).
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HUFA in DBS after 1 and 3 days in open air without
BHT, with a subsequent return to baseline levels begin-
ning at 7 days of storage is intriguing. This may reflect a
higher degradation rate of susceptible omega-3 HUFA,
with degradation of susceptible n-6 HUFA eventually
“catching up” and resulting in a slight and subtle re-
bound of the % n-3 HUFA in total HUFA. In contrast,
the sum of the % of EPA + DHA decreased rapidly and
did not return under the same conditions. The % of
EPA + DHA is calculated relative to the entire fatty acid
pool including large amounts of fatty acids with rela-
tively low degradation rates including palmitic acid
(16:0), oleic acid (18:1n-9) and 18:2n-6.
Changes in the n-6/n-3 ratio support the hypothesis of
differing degradation rates between omega-3 and
omega-6 PUFA. The n-6/n-3 ratio demonstrates an in-
verse pattern as compared with the % n-3 HUFA in total
HUFA with a rapid increase followed by a slight de-
crease as time passes. The n-6 PUFA with a slower deg-
radation rate is in the numerator while the more rapidly
degrading omega-3 PUFA is in the denominator. The
differences in the n-6/n-3 ratio and % n-3 HUFA in total
HUFA are likely due to the inclusion of 18:2n-6 in the
n-6/n-3 ratio. The degradation rate of 18:2n-6 is much
slower in comparison with 18:3n-3 and HUFA, and the
amount of 18:2n-6 in whole blood is high (23.2 ± 0.4% of
total fatty acids) as compared with the other PUFA
(38.1 ± 0.8% of total fatty acids) based on baseline values.
Although fatty acid peroxidation may still be occurring,
the utilization of the % n-3 HUFA in total HUFA blood
biomarker may provide a more useful and robust meas-
ure of omega-3 status during storage that can mask the
effects of HUFA peroxidation and still provide an accur-
ate omega-3 assessment. Our results suggest this may
not be the case with the other omega-3 biomarkers
assessed.
In the present study, purging with nitrogen did not
provide additional protection against PUFA degradation
during the 8-week storage period. It is unclear whether
nitrogen purging would have provided additional
benefits during a longer storage period. Previously, PUFA
composition in O. cincta (springtail hexapod) has been
maintained when saponification and transesterification
was performed in nitrogen-filled headspace air [23]. In
addition, direct gassing of a dairy beverage enriched with
2% flaxseed oil with nitrogen protected against PUFA deg-
radation [24], and nitrogen has also been used to slow
oxidative degradation of perishable food products [25]. In
blood, nitrogen prevents fatty acid degradation in
phospholipids for at least four weeks in plasma and less
than four weeks in erythrocytes during storage at −20°C
[14], and in erythrocytes for at least two years when stored
at −80°C [15]. Changes in HUFA composition during
Table 2 Weight % of fatty acids in dried blood spots after BHT treatment and storage by test tube or vacuum sealing
Week 0* Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8
Test tube sealed
SFAs 37.2 ± 0.5 37.6 ± 1.1 38.1 ± 1.4 39.1 ± 0.9 36.4 ± 1.2 39.8 ± 5.2 37.3 ± 0.7 36.7 ± 0.2 41.2 ± 2.3
MUFAs 24.6 ± 0.3 25.5 ± 0.5 25.2 ± 0.7 24.1 ± 0.2 25.1 ± 0.8 24.7 ± 2.1 25.6 ± 0.8 25.7 ± 0.3 23.9 ± 1.3
N-6 FAs 29.2 ± 0.2 29.7 ± 0.4 29.0 ± 0.4 28.3 ± 0.7 29.3 ± 1.4 29.3 ± 2.8 30.2 ± 0.6 29.8 ± 0.6 28.2 ± 1.7
N-3 FAs 5.11 ± 0.12 5.15 ± 0.23 5.36 ± 0.33 4.61 ± 0.33 5.04 ± 0.47 4.86 ± 0.43 4.88 ± 0.32 4.92 ± 0.39 4.60 ± 0.39
ARA 6.45 ± 0.04 6.08 ± 0.21 6.12 ± 0.50 6.38 ± 0.46 6.97 ± 0.71 6.87 ± 0.25 6.83 ± 0.54 6.88 ± 0.57 6.51 ± 0.69
EPA 0.86 ± 0.06 0.85 ± 0.05 0.80 ± 0.06 0.86 ± 0.05 0.85 ± 0.11 0.85 ± 0.14 0.86 ± 0.04 0.87 ± 0.06 0.81 ± 0.07
DHA 1.64 ± 0.04 1.48 ± 0.07 1.55 ± 0.18 1.69 ± 0.11 1.93 ± 0.23 1.78 ± 0.05 1.79 ± 0.22 1.80 ± 0.21 1.66 ± 0.18
PUFAs 34.3 ± 0.1 34.8 ± 0.6 34.3 ± 0.7 32.9 ± 1.0 34.4 ± 1.9 34.2 ± 3.2 35.1 ± 0.6 34.7 ± 1.0 32.8 ± 2.0
HUFAs 11.6 ± 0.2 11.1 ± 0.4 11.1 ± 0.9 11.7 ± 0.8 12.9 ± 1.3 12.5 ± 0.5 12.5 ± 1.0 12.6 ± 1.0 11.9 ± 1.2
Test tube sealed under nitrogen
SFAs 37.2 ± 0.5 37.3 ± 1.4 35.4 ± 0.3 37.7 ± 1.1 36.0 ± 0.2 36.3 ± 1.1 35.4 ± 0.4 37.1 ± 0.8 36.3 ± 1.4
MUFAs 24.6 ± 0.3a 25.3 ± 0.5ab 26.3 ± 0.4bcd 26.0 ± 0.2bcd 26.5 ± 0.2bcd 25.8 ± 1.2abc 26.7 ± 0.2bcd 26.9 ± 0.7cd 27.4 ± 0.5d
N-6 FAs 29.2 ± 0.2ab 29.7 ± 0.6abc 29.9 ± 0.5abc 28.7 ± 0.5a 30.5 ± 0.4abc 30.6 ± 0.7bc 31.1 ± 0.4c 29.7 ± 0.6abc 29.4 ± 1.2abc
N-3 FAs 5.11 ± 0.12ab 5.29 ± 0.04a 5.44 ± 0.11a 4.27 ± 0.09d 4.61 ± 0.14cd 5.10 ± 0.30ab 4.82 ± 0.18bc 4.37 ± 0.12d 4.41 ± 0.18cd
ARA 6.45 ± 0.04abc 6.25 ± 0.08ab 6.13 ± 0.28ab 5.96 ± 0.15a 6.37 ± 0.16ab 7.04 ± 0.49c 6.68 ± 0.19bc 6.07 ± 0.16ab 6.28 ± 0.21ab
EPA 0.86 ± 0.06abc 0.81 ± 0.02abc 0.80 ± 0.06abc 0.76 ± 0.04a 0.84 ± 0.05abc 0.91 ± 0.01c 0.89 ± 0.04bc 0.78 ± 0.03a 0.78 ± 0.05ab
DHA 1.64 ± 0.04ab 1.60 ± 0.04a 1.52 ± 0.13a 1.47 ± 0.05a 1.56 ± 0.04a 1.86 ± 0.22b 1.66 ± 0.08ab 1.46 ± 0.05a 1.51 ± 0.05a
PUFAs 34.3 ± 0.1abc 35.0 ± 0.6abc 35.3 ± 0.6bc 33.0 ± 0.6a 35.1 ± 0.5bc 35.7 ± 0.4bc 35.9 ± 0.6c 34.1 ± 0.7abc 33.8 ± 1.4ab
HUFAs 11.6 ± 0.2ab 11.2 ± 0.1ab 11.2 ± 0.4ab 10.6 ± 0.3a 11.5 ± 0.3ab 12.9 ± 1.0c 12.1 ± 0.4bc 11.0 ± 0.3ab 11.3 ± 0.4ab
Vacuum sealed
SFAs 37.2 ± 0.5 36.5 ± 0.3 37.6 ± 1.1 37.5 ± 1.7 36.7 ± 0.5 35.3 ± 0.6 35.6 ± 0.5 36.7 ± 0.9 36.9 ± 2.2
MUFAs 24.6 ± 0.3a 26.3 ± 0.1b 26.7 ± 0.5b 26.0 ± 0.4ab 26.7 ± 1.0bc 27.8 ± 0.2c 28.1 ± 0.6c 27.8 ± 0.6c 28.0 ± 0.5c
N-6 FAs 29.2 ± 0.2 29.6 ± 0.4 28.6 ± 1.2 28.7 ± 0.6 28.2 ± 1.7 30.0 ± 0.1 29.1 ± 0.7 29.1 ± 0.6 28.5 ± 1.7
N-3 FAs 5.11 ± 0.12a 5.30 ± 0.16a 5.17 ± 0.07a 4.54 ± 0.19b 4.30 ± 0.20b 4.59 ± 0.07b 4.38 ± 0.20b 4.29 ± 0.06b 4.18 ± 0.32b
ARA 6.45 ± 0.04a 6.23 ± 0.16ab 5.49 ± 0.57b 6.15 ± 0.19ab 5.84 ± 0.29ab 6.28 ± 0.07ab 6.04 ± 0.20ab 6.00 ± 0.08ab 5.87 ± 0.40ab
EPA 0.86 ± 0.06a 0.78 ± 0.02ab 0.77 ± 0.05ab 0.80 ± 0.04ab 0.76 ± 0.06ab 0.81 ± 0.02ab 0.76 ± 0.04ab 0.73 ± 0.01b 0.72 ± 0.06b
DHA 1.64 ± 0.04a 1.58 ± 0.05abc 1.36 ± 0.14c 1.60 ± 0.08ab 1.46 ± 0.08abc 1.58 ± 0.05abc 1.51 ± 0.06abc 1.46 ± 0.01abc 1.41 ± 0.10ab
PUFAs 34.3 ± 0.1 34.9 ± 0.5 33.8 ± 1.1 33.3 ± 0.8 32.5 ± 1.9 34.6 ± 0.2 33.5 ± 0.9 33.5 ± 0.6 32.7 ± 2.0
HUFAs 11.6 ± 0.2a 11.3 ± 0.3ab 10.1 ± 1.0b 11.2 ± 0.4ab 10.6 ± 0.6ab 11.5 ± 0.2ab 11.0 ± 0.4ab 10.8 ± 0.2ab 10.6 ± 0.7ab
Nitrogen dried vacuum sealed
SFAs 37.2 ± 0.5 34.8 ± 0.9 35.9 ± 0.1 37.3 ± 1.2 37.6 ± 1.7 35.7 ± 0.5 36.0 ± 1.5 37.9 ± 3.2 35.4 ± 0.7
MUFAs 24.6 ± 0.3a 27.2 ± 0.1bcd 27.0 ± 0.2bc 26.6 ± 0.7b 27.0 ± 0.4bc 28.1 ± 0.3de 27.7 ± 0.5cd 28.2 ± 0.3de 28.7 ± 0.3e
N-6 FAs 29.2 ± 0.2 30.1 ± 0.5 29.4 ± 0.1 28.7 ± 0.9 28.4 ± 0.9 29.7 ± 0.2 29.1 ± 0.8 27.7 ± 2.3 29.5 ± 0.3
N-3 FAs 5.11 ± 0.12a 5.10 ± 0.17a 5.10 ± 0.29a 4.41 ± 0.10b 4.31 ± 0.14b 4.46 ± 0.11ab 4.38 ± 0.21b 4.01 ± 0.50b 4.34 ± 0.13b
ARA 6.45 ± 0.04 6.24 ± 0.22 6.03 ± 0.03 6.02 ± 0.26 5.98 ± 0.19 6.16 ± 0.11 6.06 ± 0.29 5.70 ± 0.54 6.12 ± 0.14
EPA 0.86 ± 0.06a 0.80 ± 0.04ab 0.76 ± 0.02ab 0.77 ± 0.02ab 0.73 ± 0.04b 0.77 ± 0.02ab 0.75 ± 0.04ab 0.68 ± 0.08b 0.75 ± 0.03ab
DHA 1.64 ± 0.04 1.56 ± 0.10 1.49 ± 0.02 1.50 ± 0.09 1.49 ± 0.04 1.52 ± 0.06 1.52 ± 0.07 1.37 ± 0.16 1.47 ± 0.04
PUFAs 34.3 ± 0.1 35.2 ± 0.6 34.5 ± 0.2 33.1 ± 1.0 32.7 ± 1.0 34.2 ± 0.3 33.5 ± 1.0 31.7 ± 2.8 33.8 ± 0.5
HUFAs 11.6 ± 0.2 11.3 ± 0.5 10.9 ± 0.1 11.0 ± 0.4 10.8 ± 0.4 11.2 ± 0.2 11.0 ± 0.5 10.1 ± 1.4 11.1 ± 0.3
Values are means ± SD, n = 3. *Week 0 data baseline is the same analysis for all four storage conditions. SFA, saturated fatty acid; MUFA, monounsaturated fatty
acid; FA, fatty acid; n-6, omega-6; n-3, omega-3; ARA, arachidonic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; PUFA, polyunsaturated fatty acid;
HUFA, highly unsaturated fatty acid. Values with different superscript letters within a row are significantly different by Tukey’s HSD post hoc procedure (P < 0.05)
after a significant F-value by one-way ANOVA (P < 0.05).
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Figure 2 Omega-3 blood biomarkers in dried blood spot
samples after storage for 8 weeks in either a test tube, test
tube under nitrogen, vacuum sealed bag or nitrogen dried in
vacuum sealed bag. PUFA, polyunsaturated fatty acid; HUFA, highly
unsaturated fatty acid; EPA, eicosapentaenoic acid; DHA,
docosahexaenoic acid; DPAn-3, omega-3 docosapentaenoic acid;
n-3, omega-3; n-6, omega-6; TT, test tube storage; NTT, test tube
storage after nitrogen purging; VS, vacuum sealing in polypropylene
bag; NVS, vacuum sealing in polypropylene bag after nitrogen
purging. Bars represent means with error bars representing the S.D.,
n = 3. Bars with different letters within a storage condition are
significantly different by Tukey’s HSD post hoc procedure (P < 0.05)
after a significant F-value by one-way ANOVA (P < 0.05).
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may not be the only contributor towards peroxidation in
blood samples during storage. In previous studies, erythro-
cyte exposure to air and pure oxygen in vitro for 48 hours
at either 37, 26 or 4°C did not result in increased lipid
peroxidation as measured by malondialdehyde formation
[26]. Plasma bubbled with nitrogen and stored at −20°C
also did not prevent PUFA degradation [27]. In healthy
cells, approximately 3% of Hemoglobin(Hb)-(Iron)Fe2+ is
converted to Hb-Fe3+ resulting in production of superoxide
radicals (·O2) [28-30] that can generate lipid peroxyl
radicals and lipid hydroperoxides. If the hydroperoxides are
not efficiently removed, they can decompose to form more
free radicals in the presence of iron that can further exacer-
bate oxidative damage [31]. Thus, PUFA degradation in the
present study may be a result of Fe2+-induced peroxidation
mechanisms, and BHT has been shown to completely pre-
vent this mechanism of PUFA peroxidation [31-33]. Other
potential mechanisms of degradation may include light ex-
posure, thermal degradation and humidity. Although hu-
midity was not controlled for, all samples were stored in
the absence of light and at a constant room temperature.
The present study has limitations. Our conclusions are
limited to a single individual. A single, homogenous
blood sample was used to enable extensive time point
characterization of the PUFA degradation and restrict
variation to the degradation process. Further assessment
of the stability of PUFA in DBS samples need to be
conducted on larger cohorts where the influence of
other pro- and anti-oxidant blood materials on fatty acid
degradation can be addressed. The current study how-
ever provides valuable information and timepoints and
storage conditions to be examined. An additional limita-
tion is that the baseline PUFA and HUFA levels were
higher in study one as compared with baseline values in
study two. Although blood samples for study one (different
BHT levels) and study two (sealed storage comparisons)
were taken from the same individual, they were collected at
different time points. As such, comparing results between
study one and study two must be made with caution as
the potential for PUFA degradation may have been
Metherel et al. Lipids in Health and Disease 2013, 12:22 Page 8 of 9
http://www.lipidworld.com/content/12/1/22increased in study one. Total omega-3 PUFA measures of
approximately 4% in study one and 5% in study two are
higher than average DBS values determined in young Can-
adian adults [9], but similar to values determined in an
elderly Canadian population [8]. The higher omega-3
fatty acid composition of blood with the potential for
increased peroxidation in the present study may there-
fore underestimate the PUFA stability of DBS samples
from the general North American population.Conclusions
Pretreatment of chromatography paper with BHT for DBS
sampling may protect against PUFA degradation in a con-
centration dependent manner for up to 21 days at room
temperature, and subsequent sealing of DBS in test tubes
or vacuumed polypropylene bags can further protect
against PUFA degradation for a minimum of 8 weeks. The
% n-3 HUFA in total HUFA biomarker appears more re-
sistant to changes due to PUFA degradation given it is a
calculation based on fatty acids with relatively similar
peroxidation rates. The % n-3 HUFA in total HUFA may
have the potential to provide more accurate determinations
of omega-3 fatty acid status following extended DBS sto-
rage. Future studies on the mechanisms of PUFA degra-
dation during DBS storage to determine the main
determinant of oxidation are required. Improving storage
methods for DBS samples to allow for storage at room
temperature would be beneficial for population screening
for omega-3 biomarker determinations of disease risk and
nutritional intake, and in field studies, particularly in
developing countries and communities where clinical
resources may be limited.
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